Cecal ligation and puncture-induced impairment of innate immune function does not occur in the absence of caspase-1

Journal of Immunology

Volumn 187, Issue 2, 2011, Pages 905-910

  Murphey, E D ^a,b  

^a University of Texas Medical Branch School of Medicine   (United States)

^b UNIVERSITY OF TEXAS MEDICAL BRANCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 18; INTERLEUKIN 1BETA; INTERLEUKIN 1BETA CONVERTING ENZYME;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BACTERIAL CLEARANCE; CECAL LIGATION AND PUNCTURE; CELL STIMULATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENZYME ACTIVITY; ENZYME INDUCTION; GRANULOCYTE; INNATE IMMUNITY; MACROPHAGE; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PSEUDOMONAS AERUGINOSA; PUNCTURE; SPLEEN CELL; WILD TYPE;

ANIMALS; CASPASE 1; CECUM; DOWN-REGULATION; GENE EXPRESSION REGULATION, ENZYMOLOGIC; IMMUNE TOLERANCE; IMMUNITY, INNATE; LIGATION; MALE; MICE; MICE, 129 STRAIN; MICE, INBRED C57BL; MICE, INBRED NOD; MICE, KNOCKOUT; PSEUDOMONAS INFECTIONS; PUNCTURES; SPLEEN;

EID: 79960540366     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1002102     Document Type: Article

References (32)

1. Murphey, E. D., and E. R. Sherwood. 2006. Bacterial clearance and mortality are not improved by a combination of IL-10 neutralization and IFN-gamma administration in a murine model of post-CLP immunosuppression. Shock 26: 417-424.
2. Murphey, E. D., C. Y. Lin, R. W. McGuire, T. Toliver-Kinsky, D. N. Herndon, and E. R. Sherwood. 2004. Diminished bacterial clearance is associated with decreased IL-12 and interferon-gamma production but a sustained proinflammatory response in a murine model of postseptic immunosuppression. Shock 21: 415-425.
3. Muenzer, J. T., C. G. Davis, K. Chang, R. E. Schmidt, W. M. Dunne, C. M. Coopersmith, and R. S. Hotchkiss. 2010. Characterization and modulation of the immunosuppressive phase of sepsis. Infect. Immun. 78: 1582-1592.
4. Nhan, T. Q., W. C. Liles, and S. M. Schwartz. 2006. Physiological functions of caspases beyond cell death. Am. J. Pathol. 169: 729-737.
5. Thornberry, N. A., H. G. Bull, J. R. Calaycay, K. T. Chapman, A. D. Howard, M. J. Kostura, D. K. Miller, S. M. Molineaux, J. R. Weidner, J. Aunins, et al. 1992. A novel heterodimeric cysteine protease is required for interleukin-1 beta processing in monocytes. Nature 356: 768-774.
6. Martinon, F., and J. Tschopp. 2004. Inflammatory caspases: linking an intracellular innate immune system to autoinflammatory diseases. Cell 117: 561-574. (Pubitemid 38692523)
7. Shao, W., G. Yeretssian, K. Doiron, S. N. Hussain, and M. Saleh. 2007. The caspase-1 digestome identifies the glycolysis pathway as a target during infection and septic shock. J. Biol. Chem. 282: 36321-36329.
8. Miura, M., H. Zhu, R. Rotello, E. A. Hartwieg, and J. Yuan. 1993. Induction of apoptosis in fibroblasts by IL-1 beta-converting enzyme, a mammalian homolog of the C. elegans cell death gene ced-3. Cell 75: 653-660. (Pubitemid 23346364)
9. Mariathasan, S., D. S. Weiss, V. M. Dixit, and D. M. Monack. 2005. Innate immunity against Francisella tularensis is dependent on the ASC/caspase-1 axis. J. Exp. Med. 202: 1043-1049.
10. Li, P., H. Allen, S. Banerjee, S. Franklin, L. Herzog, C. Johnston, J. McDowell, M. Paskind, L. Rodman, J. Salfeld, et al. 1995. Mice deficient in IL-1 betaconverting enzyme are defective in production of mature IL-1 beta and resistant to endotoxic shock. Cell 80: 401-411.
11. Wichterman, K. A., A. E. Baue, and I. H. Chaudry. 1980. Sepsis and septic shock - a review of laboratory models and a proposal. J. Surg. Res. 29: 189-201.
12. Lowry, S. F., S. Awad, H. Ford, W. Cheadle, M. D. Williams, R. L. Qualy, J. S. McCollam, B. M. Bates, D. E. Fry; PROWESS Surgical Evaluation Committee. 2004. Static and dynamic assessment of biomarkers in surgical patients with severe sepsis. Surg. Infect. (Larchmt) 5: 261-268.
13. Monneret, G., M. E. Finck, F. Venet, A. L. Debard, J. Bohé, J. Bienvenu, and A. Lepape. 2004. The anti-inflammatory response dominates after septic shock: association of low monocyte HLA-DR expression and high interleukin-10 concentration. Immunol. Lett. 95: 193-198.
14. Murphy, T., H. Paterson, S. Rogers, J. A. Mannick, and J. A. Lederer. 2003. Use of intracellular cytokine staining and bacterial superantigen to document suppression of the adaptive immune system in injured patients. Ann. Surg. 238: 401-410, discussion 410-411.
15. Murphy, T. J., H. M. Paterson, J. A. Mannick, and J. A. Lederer. 2004. Injury, sepsis, and the regulation of Toll-like receptor responses. J. Leukoc. Biol. 75: 400-407.
16. Natanson, C., W. D. Hoffman, A. F. Suffredini, P. Q. Eichacker, and R. L. Danner. 1994. Selected treatment strategies for septic shock based on proposed mechanisms of pathogenesis. Ann. Intern. Med. 120: 771-783.
17. Zeni, F., B. Freeman, and C. Natanson. 1997. Anti-inflammatory therapies to treat sepsis and septic shock: a reassessment. Crit. Care Med. 25: 1095-1100.
18. Osuchowski, M. F., K. Welch, H. Yang, J. Siddiqui, and D. G. Remick. 2007. Chronic sepsis mortality characterized by an individualized inflammatory response. J. Immunol. 179: 623-630.
19. Xiao, H., J. Siddiqui, and D. G. Remick. 2006. Mechanisms of mortality in early and late sepsis. Infect. Immun. 74: 5227-5235.
20. Oberholzer, A., C. Oberholzer, R. M. Minter, and L. L. Moldawer. 2001. Considering immunomodulatory therapies in the septic patient: should apoptosis be a potential therapeutic target? Immunol. Lett. 75: 221-224.
21. Delogu, G., G. Famularo, G. Tellan, M. Marandola, A. Antonucci, M. Signore, S. Marcellini, and S. Moretti. 2008. Lymphocyte apoptosis, caspase activation and inflammatory response in septic shock. Infection 36: 485-487.
22. Boost, K. A., S. Hoegl, C. Hofstetter, M. Flondor, K. Stegewerth, I. Platacis, J. Pfeilschifter, H. Muhl, and B. Zwissler. 2007. Targeting caspase-1 by inhalation-therapy: effects of Ac-YVAD-CHO on IL-1 beta, IL-18 and downstream proinflammatory parameters as detected in rat endotoxaemia. Intensive Care Med. 33: 863-871. (Pubitemid 46675323)
23. Sarkar, A., M. W. Hall, M. Exline, J. Hart, N. Knatz, N. T. Gatson, and M. D. Wewers. 2006. Caspase-1 regulates Escherichia coli sepsis and splenic B cell apoptosis independently of interleukin-1beta and interleukin-18. Am. J. Respir. Crit. Care Med. 174: 1003-1010.
24. Hotchkiss, R. S., K. C. Chang, P. E. Swanson, K. W. Tinsley, J. J. Hui, P. Klender, S. Xanthoudakis, S. Roy, C. Black, E. Grimm, et al. 2000. Caspase inhibitors improve survival in sepsis: a critical role of the lymphocyte. Nat. Immunol. 1: 496-501.
25. Weber, P., P. Wang, S. Maddens, P. Sh. Wang, R. Wu, M. Miksa, W. Dong, M. Mortimore, J. M. Golec, and P. Charlton. 2009. VX-166: a novel potent small molecule caspase inhibitor as a potential therapy for sepsis. Crit. Care 13: R146.
26. Okamura, H., H. Tsutsi, T. Komatsu, M. Yutsudo, A. Hakura, T. Tanimoto, K. Torigoe, T. Okura, Y. Nukada, K. Hattori, et al. 1995. Cloning of a new cytokine that induces IFN-gamma production by T cells. Nature 378: 88-91.
27. Mariathasan, S., D. S. Weiss, K. Newton, J. McBride, K. O'Rourke, M. Roose-Girma, W. P. Lee, Y. Weinrauch, D. M. Monack, and V. M. Dixit. 2006. Cryopyrin activates the inflammasome in response to toxins and ATP. Nature 440: 228-232.
28. Sutterwala, F. S., Y. Ogura, M. Szczepanik, M. Lara-Tejero, G. S. Lichtenberger, E. P. Grant, J. Bertin, A. J. Coyle, J. E. Galán, P. W. Askenase, and R. A. Flavell. 2006. Critical role for NALP3/CIAS1/Cryopyrin in innate and adaptive immunity through its regulation of caspase-1. Immunity 24: 317-327.
29. Kanneganti, T. D., M. Lamkanfi, Y. G. Kim, G. Chen, J. H. Park, L. Franchi, P. Vandenabeele, and G. Núñez. 2007. Pannexin-1-mediated recognition of bacterial molecules activates the cryopyrin inflammasome independent of Toll-like receptor signaling. Immunity 26: 433-443. (Pubitemid 46603000)
30. Miao, E. A., C. M. Alpuche-Aranda, M. Dors, A. E. Clark, M. W. Bader, S. I. Miller, and A. Aderem. 2006. Cytoplasmic flagellin activates caspase-1 and secretion of interleukin 1beta via Ipaf. Nat. Immunol. 7: 569-575.
31. Franchi, L., A. Amer, M. Body-Malapel, T. D. Kanneganti, N. Ozören, R. Jagirdar, N. Inohara, P. Vandenabeele, J. Bertin, A. Coyle, et al. 2006. Cytosolic flagellin requires Ipaf for activation of caspase-1 and interleukin 1beta in salmonella-infected macrophages. Nat. Immunol. 7: 576-582.
32. Sutterwala, F. S., L. A. Mijares, L. Li, Y. Ogura, B. I. Kazmierczak, and R. A. Flavell. 2007. Immune recognition of Pseudomonas aeruginosa mediated by the IPAF/NLRC4 inflammasome. J. Exp. Med. 204: 3235-3245.